IL123322A0 - Tetrahydroquinolines their preparation and pharmaceutical compositions containing them - Google Patents
Tetrahydroquinolines their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL123322A0 IL123322A0 IL12332296A IL12332296A IL123322A0 IL 123322 A0 IL123322 A0 IL 123322A0 IL 12332296 A IL12332296 A IL 12332296A IL 12332296 A IL12332296 A IL 12332296A IL 123322 A0 IL123322 A0 IL 123322A0
- Authority
- IL
- Israel
- Prior art keywords
- tetrahydroquinolines
- preparation
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003530 tetrahydroquinolines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- AIDS & HIV (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9519893.3A GB9519893D0 (en) | 1995-09-29 | 1995-09-29 | Heterocyclic compounds |
| GBGB9617306.7A GB9617306D0 (en) | 1996-08-17 | 1996-08-17 | Heterocyclic compounds |
| PCT/EP1996/004206 WO1997012870A1 (en) | 1995-09-29 | 1996-09-26 | Tetrahydroquinolines as nmda antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL123322A0 true IL123322A0 (en) | 1998-09-24 |
Family
ID=26307841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12332296A IL123322A0 (en) | 1995-09-29 | 1996-09-26 | Tetrahydroquinolines their preparation and pharmaceutical compositions containing them |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5977136A (cs) |
| EP (1) | EP0854867B1 (cs) |
| JP (1) | JP4108123B2 (cs) |
| KR (1) | KR100464895B1 (cs) |
| CN (1) | CN1130346C (cs) |
| AP (1) | AP876A (cs) |
| AR (1) | AR005233A1 (cs) |
| AT (1) | ATE221520T1 (cs) |
| AU (1) | AU708148B2 (cs) |
| BR (1) | BR9610733A (cs) |
| CA (1) | CA2232509A1 (cs) |
| CZ (1) | CZ292379B6 (cs) |
| DE (1) | DE69622731T2 (cs) |
| DK (1) | DK0854867T3 (cs) |
| EA (1) | EA000875B1 (cs) |
| ES (1) | ES2180799T3 (cs) |
| HU (1) | HUP9900040A3 (cs) |
| IL (1) | IL123322A0 (cs) |
| IS (1) | IS4677A (cs) |
| MX (1) | MX9801967A (cs) |
| NO (1) | NO310355B1 (cs) |
| NZ (1) | NZ319596A (cs) |
| PL (1) | PL186781B1 (cs) |
| PT (1) | PT854867E (cs) |
| SI (1) | SI0854867T1 (cs) |
| TR (1) | TR199800531T1 (cs) |
| TW (1) | TW460465B (cs) |
| WO (1) | WO1997012870A1 (cs) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9617305D0 (en) | 1996-08-17 | 1996-09-25 | Glaxo Wellcome Spa | Heterocyclic compounds |
| GB9706294D0 (en) * | 1997-03-26 | 1997-05-14 | Glaxo Wellcome Spa | Heterocyclic compound |
| MY125037A (en) * | 1998-06-10 | 2006-07-31 | Glaxo Wellcome Spa | 1,2,3,4 tetrahydroquinoline derivatives |
| TW555757B (en) * | 1998-07-31 | 2003-10-01 | Akzo Nobel Nv | Aminomethylcarboxylic acid derivatives |
| CA2339662A1 (en) * | 1998-08-07 | 2000-02-17 | Takeda Chemical Industries, Ltd. | Benzothiepin derivatives, their production and use |
| GB9929037D0 (en) | 1999-12-08 | 2000-02-02 | Glaxo Wellcome Spa | Heterocyclic derivatives |
| US7307075B2 (en) * | 2001-12-28 | 2007-12-11 | Acadia Pharmaceuticals Inc. | Tetrahydroquinoline analogues as muscarinic agonists |
| DE10236910A1 (de) * | 2002-08-12 | 2004-03-11 | Grünenthal GmbH | Substituierte 1,2,3,4-Tetrahydrochinolinderivate |
| RU2451014C2 (ru) * | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
| EP1908753B1 (en) * | 2005-07-22 | 2014-12-17 | Mochida Pharmaceutical Co., Ltd. | Novel heterocyclidene acetamide derivative |
| CN102015722A (zh) * | 2008-03-05 | 2011-04-13 | 贝林格尔.英格海姆国际有限公司 | 三环吡啶衍生物、包含此类化合物的药物、它们的用途及其制备方法 |
| EP2286808A1 (en) * | 2009-08-18 | 2011-02-23 | Rheinische Friedrich-Wilhelms Universität | Cytohesin inhibitors |
| IN2012DN06631A (cs) | 2010-02-16 | 2015-10-23 | Pfizer | |
| EA201201160A1 (ru) | 2010-02-19 | 2013-04-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Трициклические производные пиридина, лекарственные средства, содержащие такие соединения, их применение и способ их получения |
| EP2760868B1 (en) | 2011-08-17 | 2018-04-25 | Boehringer Ingelheim International GmbH | Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation |
| WO2016114655A1 (en) * | 2015-01-12 | 2016-07-21 | Ry Pharma B.V. | Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation |
| WO2017065602A1 (en) * | 2015-10-13 | 2017-04-20 | Ry Pharma B.V. | Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69029668T2 (de) * | 1989-03-08 | 1997-08-07 | Merck Sharp & Dohme | Tetrahydroquinolin-Derivate, verwendbar bei neurodegenerativen Krankheiten |
-
1996
- 1996-09-26 TR TR1998/00531T patent/TR199800531T1/xx unknown
- 1996-09-26 NZ NZ319596A patent/NZ319596A/en not_active IP Right Cessation
- 1996-09-26 DK DK96933399T patent/DK0854867T3/da active
- 1996-09-26 ES ES96933399T patent/ES2180799T3/es not_active Expired - Lifetime
- 1996-09-26 BR BR9610733A patent/BR9610733A/pt not_active IP Right Cessation
- 1996-09-26 EA EA199800230A patent/EA000875B1/ru not_active IP Right Cessation
- 1996-09-26 AT AT96933399T patent/ATE221520T1/de not_active IP Right Cessation
- 1996-09-26 PT PT96933399T patent/PT854867E/pt unknown
- 1996-09-26 AP APAP/P/1998/001212A patent/AP876A/en active
- 1996-09-26 JP JP51394797A patent/JP4108123B2/ja not_active Expired - Fee Related
- 1996-09-26 HU HU9900040A patent/HUP9900040A3/hu unknown
- 1996-09-26 WO PCT/EP1996/004206 patent/WO1997012870A1/en active IP Right Grant
- 1996-09-26 DE DE69622731T patent/DE69622731T2/de not_active Expired - Lifetime
- 1996-09-26 IL IL12332296A patent/IL123322A0/xx not_active IP Right Cessation
- 1996-09-26 PL PL96325966A patent/PL186781B1/pl not_active IP Right Cessation
- 1996-09-26 CN CN96198560A patent/CN1130346C/zh not_active Expired - Fee Related
- 1996-09-26 CA CA002232509A patent/CA2232509A1/en not_active Abandoned
- 1996-09-26 KR KR10-1998-0702321A patent/KR100464895B1/ko not_active Expired - Fee Related
- 1996-09-26 US US09/029,860 patent/US5977136A/en not_active Expired - Fee Related
- 1996-09-26 AU AU72148/96A patent/AU708148B2/en not_active Ceased
- 1996-09-26 CZ CZ1998940A patent/CZ292379B6/cs not_active IP Right Cessation
- 1996-09-26 SI SI9630523T patent/SI0854867T1/xx unknown
- 1996-09-26 EP EP96933399A patent/EP0854867B1/en not_active Expired - Lifetime
- 1996-09-30 AR ARP960104543A patent/AR005233A1/es active IP Right Grant
- 1996-10-04 TW TW085112168A patent/TW460465B/zh not_active IP Right Cessation
-
1998
- 1998-02-27 IS IS4677A patent/IS4677A/is unknown
- 1998-03-12 MX MX9801967A patent/MX9801967A/es not_active IP Right Cessation
- 1998-03-27 NO NO19981396A patent/NO310355B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL117860A0 (en) | Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them | |
| IL121236A0 (en) | Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them | |
| IL122293A0 (en) | Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them | |
| IL117636A0 (en) | Taxoids their preparation and pharmaceutical compositions containing them | |
| ZA9610737B (en) | Taxoids their preparation and pharmaceutical compositions containing them | |
| IL116851A (en) | 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them | |
| IL111518A (en) | Isoquinolines their preparation and pharmaceutical compositions containing them | |
| IL119995A0 (en) | Pyrido-fused thienyl - and furanyl-oxazolidinones their preparation and pharmaceutical compositions containing them | |
| IL122618A0 (en) | Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them | |
| IL121235A0 (en) | Bicyclic-fused pyridines their preparation and pharmaceutical compositions containing them | |
| IL115905A0 (en) | Sordarin derivatives their preparation and pharmaceutical compositions containing them | |
| IL119559A0 (en) | Purin -6- one derivatives their preparation and pharmaceutical compositions containing them | |
| IL117349A0 (en) | N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them | |
| IL119316A0 (en) | Hydroxypyridinones their preparation and pharmaceutical compositions containing them | |
| IL125710A0 (en) | Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them | |
| IL117554A0 (en) | Imidazoquinazolines their preparation and pharmaceutical compositions containing them | |
| IL112889A (en) | Beta-lactams their preparation and pharmaceutical compositions containing them | |
| IL117815A0 (en) | Ascomycins their preparation and pharmaceutical compositions containing them | |
| IL123322A0 (en) | Tetrahydroquinolines their preparation and pharmaceutical compositions containing them | |
| IL117878A (en) | Taxoids their preparation and pharmaceutical compositions containing them | |
| ZA967800B (en) | Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them | |
| ZA962633B (en) | Taxoids their preparation and pharmaceutical compositions containing them | |
| IL118054A0 (en) | (Het) aryloxy-,(-thio- and -amino-)-crotonates their preparation and pharmaceutical compositions containing them | |
| IL118672A (en) | Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them | |
| IL119371A0 (en) | Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |